MakCHS Publications

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 12 results

Author [ Keyword

] Title Type Year

Filters: Author is Maggiolo, Franco [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Adult

D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., “Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”, AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.

Aged

D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., “Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”, AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.

AIDS-Related Opportunistic Infections

D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., “Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”, AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.

Antiretroviral Therapy, Highly Active

D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., “Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”, AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.

Female

D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., “Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”, AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.

Hepatitis C

D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., “Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”, AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.

HIV Infections

D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., “Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”, AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.

Humans

D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., “Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”, AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.

Male

D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., “Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”, AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.

Middle Aged

D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., “Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”, AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.

Patient Acceptance of Health Care

D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., “Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”, AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.

Risk Factors

D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F., “Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”, AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.